Optimal Tube Feeding Method in Head and Neck Cancer Patients
NCT01536782 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2026-04-29
Summary
The purpose of this study is to assess the optimal tube feeding method (bolus, gravity or pump) by analyzing percent weight loss, tolerance of enteral feeds, and percent of estimated calorie and protein needs in 60 patients with squamous cell carcinoma of the head and neck undergoing chemoradiation therapy.
Conditions
Interventions
- PROCEDURE
-
Bolus
The patients will be randomized into 3 different groups: Bolus, Gravity, and Pump. The randomization process will be based on age and estimated caloric needs (i.e if we have three 60-year-old patients whose estimated kcals needs are ≤ 1900kcals/day, then each patient will be randomized to either of the groups). Each patient from each group will be receiving tube feeding education to their by RD. For consistency reasons, the same type of tube feeding formula (1.5 kcal/ml, no fiber) will be used. Patients' weight, tube feeding tolerance, and amount of estimated calories and protein met will be monitored weekly.
- PROCEDURE
-
Gravity
The patients will be randomized into 3 different groups: Bolus, Gravity, and Pump. The randomization process will be based on age and estimated caloric needs (i.e if we have three 60-year-old patients whose estimated kcals needs are ≤ 1900kcals/day, then each patient will be randomized to either of the groups). Each patient from each group will be receiving tube feeding education to their by RD. For consistency reasons, the same type of tube feeding formula (1.5 kcal/ml, no fiber) will be used. Patients' weight, tube feeding tolerance, and amount of estimated calories and protein met will be monitored weekly.
- DEVICE
-
Pump
The patients will be randomized into 3 different groups: Bolus, Gravity, and Pump. The randomization process will be based on age and estimated caloric needs (i.e if we have three 60-year-old patients whose estimated kcals needs are ≤ 1900kcals/day, then each patient will be randomized to either of the groups). Each patient from each group will be receiving tube feeding education to their by RD. For consistency reasons, the same type of tube feeding formula (1.5 kcal/ml, no fiber) will be used. Patients' weight, tube feeding tolerance, and amount of estimated calories and protein met will be monitored weekly.
Sponsors & Collaborators
-
Baylor Research Institute
lead OTHER
Principal Investigators
-
Andreea Nguyen, MS in Nutrition · Baylor Health Care System
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2016-12-31
- Completion
- 2017-02-28
Countries
- United States
Study Locations
More Related Trials
-
Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer
NCT00629226 ·Status: COMPLETED ·Phase: PHASE1
-
Low-Carbohydrate Normocaloric Diet in Patients With Head and Neck Carcinoma (HNC)
NCT02555176 ·Status: COMPLETED ·Phase: NA
-
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
NCT03010150 ·Status: RECRUITING
-
Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC
NCT00162708 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer
NCT06775756 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
NCT07338487 ·Status: RECRUITING ·Phase: PHASE1
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck
NCT02201355 ·Status: TERMINATED ·Phase: PHASE1
-
Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer
NCT00176267 ·Status: COMPLETED ·Phase: PHASE2
-
App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy
NCT06367257 ·Status: RECRUITING ·Phase: NA
-
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
NCT06136962 ·Status: NOT_YET_RECRUITING
-
Feasibility of a Carbohydrate-restricted, High-fat Diet on Head and Neck Squamous Cell Carcinoma Outcomes
NCT04253808 ·Status: COMPLETED ·Phase: NA
-
Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer
NCT00301028 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer
NCT00001442 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer
NCT01667211 ·Status: UNKNOWN ·Phase: PHASE2
-
Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer
NCT02262221 ·Status: SUSPENDED ·Phase: NA
-
A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC
NCT06793761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Immunonutrition Supplementation in Head and Neck Cancer Patients Undergoing Cancer Treatment Study
NCT05526040 ·Status: UNKNOWN ·Phase: NA
-
Induction Chemotherapy Followed by Chemoradiotherapy for Head and Neck Cancer
NCT01716195 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
NCT02126969 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
NCT00002922 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
NCT01847326 ·Status: COMPLETED ·Phase: PHASE1
-
Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck
NCT02236936 ·Status: TERMINATED ·Phase: PHASE3
-
Nutritional Status of Head and Neck Cancer Patients
NCT07068711 ·Status: RECRUITING
-
Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma
NCT04678791 ·Status: NOT_YET_RECRUITING ·Phase: NA